Design, synthesis, and anti-Toxoplasma gondii evaluation of β-carboline derivatives
Zhendi Liu, Yongmei Li, Yetian Li, Xiaoyu Han, Hongda Qiu, Chang Qin, Yuchao Zhu, Weida Liang, Jiao Mo, Zixun Yan, Weixin Gao, Jiyu Zhang, Jishan Zheng, Hongze Liang, Jili Zhang · 2025
Read Design, synthesis, and anti-Toxoplasma gondii evaluation of β-carboline derivatives by Zhendi Liu, Yongmei Li, Yetian Li, Xiaoyu Han, Hongda Qiu, Chang Qin, Yuchao Zhu, Weida Liang, Jiao Mo, Zixun Yan, Weixin Gao, Jiyu Zhang, Jishan Zheng, Hongze Liang, Jili Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750888.txt.
Description
Zhendi Liu and co-authors published this 2025 study on new compounds against a common parasite. Toxoplasma gondii infects many people and animals, and current drugs carry harsh side effects. The team made a family of compounds based on a plant-like scaffold called beta-carboline. They tested the set against the parasite in dishes and in mice.
Safety checks on mammal cells came first, then plaque and gene-based tests for anti-parasite strength. Two compounds stood out, beating the parasite's growth in both its fast and slow strains at low doses. Microscope images showed damaged parasite structure and signs of cell death. Mouse tests added proof the compounds can work in a living body. The work offers fresh leads for safer treatment.
Catalog record
| CREATOR | Zhendi Liu, Yongmei Li, Yetian Li, Xiaoyu Han, Hongda Qiu, Chang Qin, Yuchao Zhu, Weida Liang, Jiao Mo, Zixun Yan, Weixin Gao, Jiyu Zhang, Jishan Zheng, Hongze Liang, Jili Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |